Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study

Cholangiocarcinoma (CCA) is a highly lethal disease because most patients are asymptomatic until they progress to advanced stages. Current CCA diagnosis relies on clinical imaging tests and tissue biopsy, while specific CCA biomarkers are still lacking. This study employed a translational proteomic...

Descripción completa

Detalles Bibliográficos
Autores principales: Watcharatanyatip, Kamolwan, Chutipongtanate, Somchai, Chokchaichamnankit, Daranee, Weeraphan, Churat, Mingkwan, Kanokwan, Luevisadpibul, Virat, Newburg, David S., Morrow, Ardythe L., Svasti, Jisnuson, Srisomsap, Chantragan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501115/
https://www.ncbi.nlm.nih.gov/pubmed/36144640
http://dx.doi.org/10.3390/molecules27185904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501115/
https://www.ncbi.nlm.nih.gov/pubmed/36144640
http://dx.doi.org/10.3390/molecules27185904

Ejemplares similares